Verve Human Care Laboratories Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Verve Human Care Laboratories Pharmaceutical Export Portfolio Dataset — 4 Products, $944.7K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Verve Human Care Laboratories — Pharmaceutical Exporter Profile (2026) | 4 Products, $944.7K Trade | TransData Nexus

Verve Human Care Laboratories

Indian Pharmaceutical Exporter · Analgesics & Antipyretics Specialist · $944.7K Total Trade · DGFT Verified

Verve Human Care Laboratories is an Indian pharmaceutical exporter with a total trade value of $944.7K across 4 products in 3 therapeutic categories. Based on 60 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Morphine ($367.6K), Diazepam ($329.8K), Fentanyl ($216.7K).

Verve Human Care Laboratories — Export Portfolio & Destination Treemap

Verve Human Care Laboratories pharmaceutical export portfolio — 4 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Verve Human Care Laboratories? — Company Overview & Market Position

Verve Human Care Laboratories, established in 2010, is a privately held pharmaceutical company headquartered in Dehradun, Uttarakhand, India. The company specializes in the development and manufacturing of finished pharmaceutical formulations, with a particular focus on controlled substances, including narcotics and psychotropic products. Their product portfolio encompasses a diverse range of dosage forms such as tablets, capsules, syrups, and injections.

As of March 31, 2016, Verve Human Care Laboratories reported an annual revenue of $9.25 million USD, with a net profit of $948,950 USD. The company is classified as a micro enterprise for the financial year 2023-24, indicating a workforce size of fewer than 10 employees. Their manufacturing facility is located in the pollution-free zone of Pharmacity Selaqui, Dehradun, and is designed to meet Good Manufacturing Practice (GMP) standards as specified by the World Health Organization (WHO).

What Does Verve Human Care Laboratories Export? — Product Portfolio Analysis

Top Products by Export Value

1Morphine$367.6K 2

Product Portfolio — Top 4 by Export Value

Verve Human Care Laboratories exports 4 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Morphine	Analgesics & Antipyretics	$367.6K	19	2.1%	4
2	Diazepam	CNS & Psychiatric	$329.8K	16	4.4%	6
3	Fentanyl	Analgesics & Antipyretics	$216.7K	20	5.7%	4
4	Digoxin	Cardiovascular	$30.5K	5	1.4%	11

Verve Human Care Laboratories exports 4 pharmaceutical products across 3 therapeutic categories with a total export value of $944.7K. The top category is Analgesics & Antipyretics (61.9% of portfolio), followed by CNS & Psychiatric (34.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Verve Human Care Laboratories — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Verve Human Care Laboratories operates a state-of-the-art manufacturing plant situated in Dehradun, Uttarakhand, India. The facility is designed to adhere to international standards, including WHO-GMP guidelines, ensuring the production of high-quality pharmaceutical products. The plant specializes in the production of oral pharmaceuticals, granules, and parenteral formulations, with a particular emphasis on controlled substances such as narcotics and psychotropic products.

3Key Leadership

Specific details regarding the CEO, CFO, and other key executives of Verve Human Care Laboratories are not publicly disclosed. However, the company has a dedicated team of professionals overseeing various departments, including operations, regulatory affairs, quality assurance, and international business. Notable personnel include:

Sachin Mane – Senior General Manager Operations (Plant Head)
Salamtullah Turk – Regulatory Affairs Manager
Govind Singh Chauhan – QA Officer
Priyanka Kushwaha – DRA Executive
Smarika Rana – Quality Assurance Manager
Rajesh Chhikara – Manager-DRA
Shivam Verma – Director
Yashwant Singh – Assistant General Manager
Anupam Patel – Manager-International Business and Regulatory Affairs

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Verve Human Care Laboratories Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Verve Human Care Laboratories has established a significant presence in various regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facility holds approvals from several international regulatory bodies, such as WHO-GMP (India), FMHACA (Ethiopia), MCAZ (Zimbabwe), ZAMRA (Zambia), FDA (Ghana), TMDA (Tanzania), PPB (Kenya), and NDA (Uganda). These certifications indicate compliance with stringent manufacturing standards, facilitating access to these markets. While specific regulatory filings and approvals in the U.S., EU, UK, Australia, and Japan are not detailed, the company's adherence to international standards suggests a strategic approach to market access in these regions.

2Emerging Markets

Verve Human Care Laboratories has expanded its reach into emerging markets across Africa, Latin America, Southeast Asia, and the Middle East. The company's product portfolio includes a wide spectrum of narcotics and psychotropics, such as Morphine, Fentanyl, Pethidine, Oxycodone, Codeine, Diazepam, Ketamine, Ephedrine, and Phenobarbital, available in various dosage forms including injections, tablets, and transdermal systems. The facility's compliance with WHO-GMP standards and approvals from regulatory bodies in countries like Ethiopia, Ghana, Kenya, and Uganda enhance its ability to supply high-quality pharmaceuticals to these regions.

Verve Human Care Laboratories — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Verve Human Care Laboratories' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's manufacturing facility is designed to meet international standards, including those specified by the WHO, indicating a commitment to quality and regulatory compliance.

2WHO & EU GMP

Verve Human Care Laboratories' manufacturing facility holds WHO-GMP certification, ensuring compliance with international manufacturing standards. While specific EU GMP certificates and European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not detailed, the company's adherence to WHO-GMP guidelines suggests a commitment to quality that aligns with EU standards.

3CDSCO & Indian Regulatory

Verve Human Care Laboratories holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) in India, indicating compliance with national regulatory requirements. The company's manufacturing facility is located in Dehradun, Uttarakhand, and is designed to meet WHO-GMP standards, reflecting adherence to both national and international manufacturing practices.

Verve Human Care Laboratories — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Verve Human Care Laboratories operates in a competitive market, facing competition from established players such as Unither, Akums, Jubilant Life Sciences, Recipharm, and CoreRx. The company's focus on controlled substances, including narcotics and psychotropic products, differentiates it from competitors. While specific market share comparisons are not available, the company's adherence to international manufacturing standards and possession of various regulatory approvals position it as a competent player in the pharmaceutical manufacturing sector.

2Key Differentiators

Verve Human Care Laboratories' specialization in controlled substances, including narcotics and psychotropic products, sets it apart from competitors. The company's diverse product portfolio, encompassing sterile dosage forms, transdermal drug delivery systems, oral dissolving films, and oral solid dosage forms, demonstrates its commitment to innovation and quality. Adherence to international manufacturing standards and possession of various regulatory approvals further enhance its competitive advantages.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Verve Human Care Laboratories as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Verve Human Care Laboratories has demonstrated a consistent track record in manufacturing and exporting pharmaceutical products, with a total export value of $945,000 USD across 60 shipments. The company's product portfolio includes analgesics, CNS & psychiatric medications, and cardiovascular drugs, with a concentration in the analgesics & antipyretics category. The top five products—Morphine, Diazepam, Fentanyl, Digoxin, and Clobazam—account for 100% of the company's export value, indicating a focused product strategy. The company's adherence to international manufacturing standards and possession of various regulatory approvals suggest reliability and commitment to quality.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm the company's FDA facility registrations and approved ANDAs through the FDA's official website.

WHO-GMP Certification: Verify the WHO-GMP certification status via the WHO's official website.

Frequently Asked Questions — Verve Human Care Laboratories

How many pharmaceutical products does Verve Human Care Laboratories export from India?

Verve Human Care Laboratories exports 4 pharmaceutical products across 3 therapeutic categories. The top exports are Morphine ($367.6K), Diazepam ($329.8K), Fentanyl ($216.7K), Digoxin ($30.5K). Total export value is $944.7K.

What is Verve Human Care Laboratories's total pharmaceutical export value?

Verve Human Care Laboratories's total pharmaceutical export value is $944.7K, based on 60 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Verve Human Care Laboratories cover?

Verve Human Care Laboratories exports across 3 therapeutic categories. The largest are Analgesics & Antipyretics (61.9%, 2 products), CNS & Psychiatric (34.9%, 1 products), Cardiovascular (3.2%, 1 products).

Get Full Verve Human Care Laboratories Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.